Prescription Drug Content On Social Media Often Misleading, Study Finds

A recent study found that social media influencers who promote prescription drugs may often share misleading information. Image Credit: Lucas Ottone/Stocksy. A recent review suggests that social media influencers touting prescription drugs are often spreading misinformation. The research shows that audiences have difficulty recognizing promotional intent when the marketing is embedded in personal narratives. The findings highlight a need for updated regulatory guidance and stronger, more standardized disclosure requirements. The rise of social media influencers has changed how many people get information about many products and services. A recent review published in JAMA Network Open examined how social media influencers affect how users obtain information and approach prescription medications. The researchers found that the promotion of prescription medications by social media influencers is often accompanied by misleading information. It was shown that this type of promotion can be connected to outdated regulatory oversight. “Influencers often share advice about prescription drugs despite having financial incentives or little medical expertise,” said study author Raffael Heiss, PhD, professor at the Management Center Innsbruck (MCI). “Existing rules and disclosure requirements have not kept pace with social media,” Heiss told Healthline. The review also found that audiences may have difficulty recognizing promotional intent when it’s embedded in personal narratives. “Personal stories can also make promotional content feel trustworthy and authentic, even when it is incomplete or misleading,” Heiss said. “As a result, followers may trust influencers because they emotionally connect with their stories and may not recognize that the content is advertising.” ‘Patient influencers’ and prescription drug misinformation Prescription drug companies are increasingly partnering with social media influencers, or people who attract